The wild trading in Avis Budget Group CAR +7.28% stock continued on Tuesday as shares of the rental-car company gained another 14% and have risen more than six-fold over the past month—and it could

Stock Of The Day: Will The Avis Rally Ever End?

10:32am, Tuesday, 21'st Apr 2026
Avis Budget Group, Inc.  (NASDAQ:CAR) shares have gained more than 500% in less than a month. They now appear to be in a short-squeeze.
Shares of ​car rental company Avis Budget hit a record high on Tuesday, having quadrupled ‌so far in April, as analysts pointed to a short squeeze that has dealt steep losses to investors betting
Avis Budget Group, Inc. (NASDAQ:CAR) moved higher Tuesday as equity futures climbed and Consumer Discretionary paced early sector gains. Traders leaned into momentum after CAR notched new 52-week high
Avis Budget Group (NASDAQ:CAR) shares are up 15% in early trading this Tuesday morning, defying a fresh Barclays downgrade to Underweight issued directly into the teeth of one of the most parabolic st
Avis Budget (CAR) is seeing momentum build at a pace that is starting to attract broader investor attention, with shares jumping as much as 19% in premarket tra
Avis rose nearly $88 a share, or 17.8%, to $581.83 on Monday. The stock traded at around $100 on March 20.
Avis Budget Group (NASDAQ:CAR) stock is up 11% midday Monday, climbing from $493.86 to $550 as short-sellers scramble to cover positions they can no longer afford to hold.
Car rental and used car stocks are seeing a wide divergence in their performance. Three notable names across these industries are Avis Budget Group NASDAQ: CAR, CarMax NYSE: KMX, and Carvana NYSE: CVN
The latest surge in CAR has been tied to a short squeeze after short interest rose from 8.12 million to 9.03 million shares, with 53.66% of the public float held short. With average daily volume aroun

Avis Budget: Looking Beyond The Short Squeeze

09:25am, Monday, 20'th Apr 2026
Avis Budget (CAR) stock has surged by almost 390% over the last month and rose by almost 10% in Friday's trading, driven by a powerful short squeeze.
Kelonia's lead program, KLN-1010, is a potentially first-in-class lentiviral in vivo CAR-T therapy currently in Phase 1 for relapsed/refractory multiple myeloma with clinical data recently highlighted
SOUTH SAN FRANCISCO, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloC
A lasting end to the war in Iran would almost certainly be welcome news for tech companies' bottom lines.

Why Is Avis Budget Group Stock Surging Thursday?

01:21pm, Thursday, 16'th Apr 2026
The Nasdaq is up 0.51% while the S&P 500 has gained 0.25%.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE